Pacific Biosciences Of California (PACB) Return on Capital Employed (2011 - 2026)
Pacific Biosciences Of California's quarterly Return on Capital Employed came in at 18.57% in Q1 2026, up 6412.0% year-on-year from 0.29% in Q1 2025, and up 75.84% quarter-over-quarter from 76.84% in Q4 2025.
Pacific Biosciences Of California has reported Return on Capital Employed for 16 years, with the latest figure at 18.57% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 6412.0% year-over-year to 18.57%; the trailing twelve-month figure through Mar 2026 stood at 18.57% (up 6412.0% YoY), and the FY2025 full-year result was 58.34%, down 2533.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 18.57%, up from 76.84% in the prior quarter.
- The five-year high for Return on Capital Employed was 11.17% in Q1 2022, with the low at 88.63% in Q3 2025.
- Average Return on Capital Employed over 5 years is 35.86%, with a median of 20.38% recorded in 2023.
- Year-over-year, Return on Capital Employed slumped 6283 bps in 2025 and soared 6412 bps in 2026.
- Tracing PACB's Return on Capital Employed over 5 years: stood at 20.08% in 2022, then grew by 4 bps to 19.37% in 2023, then slumped by 90 bps to 36.8% in 2024, then sank by 109 bps to 76.84% in 2025, then jumped by 76 bps to 18.57% in 2026.
- The last three Return on Capital Employed figures came in at 18.57% (Q1 2026), 76.84% (Q4 2025), and 88.63% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn | -18.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.57% |
| Dec 31, 2025 | -76.84% |
| Sep 30, 2025 | -88.63% |
| Jun 30, 2025 | -88.19% |
| Mar 31, 2025 | -82.68% |
| Dec 31, 2024 | -36.80% |
| Sep 30, 2024 | -28.80% |
| Jun 30, 2024 | -28.27% |
| Mar 31, 2024 | -19.85% |
| Dec 31, 2023 | -19.37% |
| Sep 30, 2023 | -19.77% |
| Jun 30, 2023 | -20.38% |
| Mar 31, 2023 | -20.49% |
| Dec 31, 2022 | -20.08% |
| Sep 30, 2022 | -16.13% |
| Jun 30, 2022 | -13.60% |
| Mar 31, 2022 | -11.17% |
| Jun 30, 2021 | -9.92% |
| Mar 31, 2021 | -13.18% |
| Dec 31, 2020 | -32.76% |
| Sep 30, 2020 | -77.60% |
| Jun 30, 2020 | -109.56% |
| Mar 31, 2020 | -173.60% |
| Dec 31, 2019 | -102.71% |
| Sep 30, 2019 | -105.20% |
| Jun 30, 2019 | -85.37% |
| Mar 31, 2019 | -80.68% |
| Dec 31, 2018 | -67.46% |
| Sep 30, 2018 | -65.71% |
| Jun 30, 2018 | -70.38% |
| Mar 31, 2018 | -72.02% |
| Dec 31, 2017 | -73.38% |
| Sep 30, 2017 | -63.31% |
| Jun 30, 2017 | -68.01% |
| Mar 31, 2017 | -75.04% |
| Dec 31, 2016 | -64.48% |
| Sep 30, 2016 | -43.93% |
| Jun 30, 2016 | -30.00% |
| Mar 31, 2016 | -27.38% |
| Dec 31, 2015 | -37.71% |
| Sep 30, 2015 | -77.23% |
| Jun 30, 2015 | -91.07% |
| Mar 31, 2015 | -83.04% |
| Dec 31, 2014 | -68.67% |
| Sep 30, 2014 | -64.68% |
| Jun 30, 2014 | -68.89% |
| Mar 31, 2014 | -64.76% |
| Dec 31, 2013 | -63.59% |
| Sep 30, 2013 | -67.93% |
| Mar 31, 2012 | -54.78% |
| Dec 31, 2011 | -52.57% |
| Sep 30, 2011 | -54.13% |